FDA grants accelerated approval to Aliqopa (copanlisib)

Today, we at BAST were very pleased to see the press-release that the FDA granted accelerated approaval to Aliqopa (copanlisib) for which we delivered the pharmacometrics reports for the clinical pharmacology package. It always feels good to end the week with some positive news!

Leave a Reply